These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17257889)

  • 1. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
    Nakagawa H; Matsumiya T; Sakaki H; Imaizumi T; Kubota K; Kusumi A; Kobayashi W; Kimura H
    Oral Oncol; 2007 Jul; 43(6):544-50. PubMed ID: 17257889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
    Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
    Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
    Taber SW; Fingar VH; Coots CT; Wieman TJ
    Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Chan AL; Juarez M; Allen R; Volz W; Albertson T
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy.
    Kick G; Messer G; Plewig G; Kind P; Goetz AE
    Br J Cancer; 1996 Jul; 74(1):30-6. PubMed ID: 8679454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines.
    Nakamura H; Suzuki Y; Takeichi M; Saito T; Takayama M; Aizawa K
    Int J Gynecol Cancer; 2002; 12(2):177-86. PubMed ID: 11975677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP.
    Tsai SR; Yin R; Huang YY; Sheu BC; Lee SC; Hamblin MR
    Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):123-30. PubMed ID: 25462575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung.
    Kato H; Furukawa K; Sato M; Okunaka T; Kusunoki Y; Kawahara M; Fukuoka M; Miyazawa T; Yana T; Matsui K; Shiraishi T; Horinouchi H
    Lung Cancer; 2003 Oct; 42(1):103-11. PubMed ID: 14512194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells.
    Miki Y; Akimoto J; Moritake K; Hironaka C; Fujiwara Y
    Lasers Med Sci; 2015 Aug; 30(6):1739-45. PubMed ID: 26109138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel photodynamic therapy against biliary tract carcinoma using mono-L: -aspartyl chlorine e6: basic evaluation for its feasibility and efficacy.
    Kasuya K; Shimazu M; Suzuki M; Kuroiwa Y; Usuda J; Itoi T; Tsuchida A; Aoki T
    J Hepatobiliary Pancreat Sci; 2010 May; 17(3):313-21. PubMed ID: 20464561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorin e6-mediated photodynamic therapy promotes collagen production and suppresses MMPs expression via modulating AP-1 signaling in P. acnes-stimulated HaCaT cells.
    Ryu AR; Lee MY
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():71-77. PubMed ID: 28807774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
    Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S
    Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Gomer CJ; Ferrario A
    Cancer Res; 1990 Jul; 50(13):3985-90. PubMed ID: 2354446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.
    Solban N; Selbo PK; Sinha AK; Chang SK; Hasan T
    Cancer Res; 2006 Jun; 66(11):5633-40. PubMed ID: 16740700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
    Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y
    Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy in combination with talaporfin sodium induces mitochondrial apoptotic cell death accompanied with necrosis in glioma cells.
    Miki Y; Akimoto J; Yokoyama S; Homma T; Tsutsumi M; Haraoka J; Hirano K; Beppu M
    Biol Pharm Bull; 2013; 36(2):215-21. PubMed ID: 23196427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis.
    Usuda J; Okunaka T; Furukawa K; Tsuchida T; Kuroiwa Y; Ohe Y; Saijo N; Nishio K; Konaka C; Kato H
    Int J Cancer; 2001 Aug; 93(4):475-80. PubMed ID: 11477550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.
    Sheyhedin I; Aizawa K; Araake M; Kumasaka H; Okunaka T; Kato H
    Photochem Photobiol; 1998 Jul; 68(1):110-4. PubMed ID: 9679456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy.
    Wong TW; Aizawa K; Sheyhedin I; Wushur C; Kato H
    J Pharmacol Sci; 2003 Oct; 93(2):136-42. PubMed ID: 14578580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.